Select Page

The latest report on Peptide Therapeutics Market (by drug class (luteinizing hormone (LH)-releasing hormone (LHRH), somatostatins, glucagon and analogs, insulins, vasopressin), route of administration (oral, parental), technology (liquid phase, solid phase, hybrid phase)) provides complete and deep insights into the market dynamics and growth of peptide therapeutics.

The latest information on market risks, industry chain structure peptide therapeutics cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential peptide therapeutics growth factors. The global peptide therapeutics market is growing with a CAGR between 9.0% to 9.5% from 2017 to 2023. The global peptide therapeutics market size was totaled 21.12 Billion in 2016.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Recent Technological Advancements have Reduced Production Cost of Peptide Drugs Thereby Fuelling Growth Remarkably in Global Market

Global peptide therapeutics market has experienced progressive growth over the past few years. Growth in the global market is highly credible to the rising prevalence of metabolic disorders coupled with an increasing pool of cancer patients. Moreover, recent technological advancements have reduced the production cost of peptide drugs thereby fuelling growth remarkably in the global market. Rising research activities and development pipeline of peptide drugs anticipated providing numerous growth opportunities over the forecast period. Although driven by the aforementioned factors, growth in this market is hampered by the complexity of peptide therapies may limit the manufacturing of peptide drugs.

Furthermore, consistently increasing the cancer population across the globe with technological advancements likely uncover growth opportunities throughout the forecasted period. Additionally, increasing the incidence of metabolic disorders across the globe will also be expected to create numerous growth opportunities in the forthcoming years.

Segments Make up the Peptide Therapeutics Industry

The report segments the global peptide therapeutics market by drug class, by route of administration, by technology and by region. Based on drug class segment includes luteinizing hormone (LH)-releasing hormone (LHRH), somatostatins, glucagon and analogs, insulins, vasopressin, calcitonins, and other. Based on route of administration the segment is divided into oral, parental and others. The technology segment includes a liquid phase, solid phase and hybrid phase.

Key Players in the Peptide Therapeutics Market

The companies covered in the report include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Sanofi, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Eli Lilly and Co., Bachem Holding AG, and Amgen Inc.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the peptide therapeutics.
  • Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2023.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.